Drug intelligence / Profile preview

methysergide

Development stage
Discontinued
Lead developer
Sandoz
Modality
Small Molecules
Administration
Oral
01

Overview

Methysergide is a semisynthetic ergot alkaloid and lysergamide used primarily for the prophylaxis of migraine and cluster headaches. It is not effective for acute attacks but is taken daily to prevent headache episodes. Methysergide acts as a mixed serotonin receptor modulator—antagonist at some serotonin (5-HT2) receptor and partial agonist or agonist at others (notably 5-HT1 receptor). Its mechanism involves blocking the effects of serotonin in blood vessels and gastrointestinal smooth muscle, leading to vasoconstriction, which may reduce headache frequency and severity. Methysergide is a prodrug that converts to methylergometrine in vivo. Due to risks such as retroperitoneal fibrosis, cardiac valvulopathy, and other fibrotic complications with long-term use, it has been withdrawn from markets like the United States and Canada and reserved only for severe cases unresponsive to other treatments[1][2][5][7].

Brand names
DeserilSansert
Other names
methysergide maleate
02

Targets

HTR2A (Serotonin receptor 5-HT2A)HTR2C (5-hydroxytryptamine 2C receptor)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))ADRA1A (α1A)HTR2B (5-Hydroxytryptamine Receptor 2B)HTR1D (5-hydroxytryptamine receptor 1D)

Beyond the preview

Go deeper on methysergide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methysergide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call